ARCHIVES

Commercial Firms Get Foot In The Door With CREG, But Won’t Be Permitted To Make Money On Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 02 | January 10, 1975

Download PDF Visit The Full Archive

Related Articles

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

NCAB Honors Member Who Was In Stockholm

December 9, 1988

Kidney, Bladder Cancer Causes, Treatment, Need More Research, NCI Advisors Find

July 26, 2002

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

NCAB Asks For Cost Reimbursement n Patients In Clinical Trials Until More Data Available

October 5, 1984